These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The dependence of pneumonias on the changes in the pulmonary vascular bed, in children with congenital heart defects. Erecinski K; Malecka-Dymnicka S; Bieniek B Pol Med Sci Hist Bull; 1967 Jan; 10(1):18-20. PubMed ID: 6038758 [No Abstract] [Full Text] [Related]
43. Pulmonary hypertensive necrotizing arteritis: an unusual case of unilateral involvement in an infant with congenital heart disease. Steiner I; Bolosová V; Fejtová S Pathol Res Pract; 2010 Jul; 206(7):472-5. PubMed ID: 19679401 [TBL] [Abstract][Full Text] [Related]
44. [Certain aspects of pulmonary hypertension]. Passowicz-Muszyńska E Wiad Lek; 1989 Nov 15-Dec 15; 42(22-24):1122-7. PubMed ID: 2700260 [TBL] [Abstract][Full Text] [Related]
45. [Pulmonary changes in congenital heart diseases. (Anatomical and histopathological study of 21 cases)]. Gentili M Atti Accad Fisiocrit Siena Med Fis; 1967; 16(1):585-602. PubMed ID: 5621914 [No Abstract] [Full Text] [Related]
46. Pulmonary hypertension: pathophysiology as a basis for clinical decision making. Rabinovitch M J Heart Lung Transplant; 1999 Nov; 18(11):1041-53. PubMed ID: 10598727 [No Abstract] [Full Text] [Related]
47. [Sequence of the changes in the vessels of the lungs and hypertrophy of the right heart in different forms of hypertension of the lesser circulation]. Esipova IK; Purdiaev IuS Arkh Patol; 1973; 35(11):54-8. PubMed ID: 4276262 [No Abstract] [Full Text] [Related]
48. [Pulmonary arterial hypertension associated with congenital cardiopathies]. Lago JA; Zamorano Mde M; da Cruz F Arq Bras Cardiol; 1985 Sep; 45(3):197-203. PubMed ID: 3835864 [No Abstract] [Full Text] [Related]
49. [Role of endogenous biologically active substances in the regulation of pulmonary circulation in patients with hypervolemic congenital heart defects]. Gerasimov NM; Guliamov DS; Nam LN Patol Fiziol Eksp Ter; 1995; (3):31-3. PubMed ID: 7501433 [No Abstract] [Full Text] [Related]
50. Inhaled nitric oxide for pulmonary hypertension in patients with and without congenital heart disease: just say no! Atz AM; Simsic JM J S C Med Assoc; 1999 Sep; 95(9):349-51. PubMed ID: 10510601 [No Abstract] [Full Text] [Related]
51. Problems of pulmonary hypertension in children with congenital cardiac defects. Rabinovitch M Chest; 1988 Mar; 93(3 Suppl):119S-126S. PubMed ID: 3277814 [No Abstract] [Full Text] [Related]
52. Pulmonary hypertension associated with congenital heart disease: a practical review for the pediatric cardiologist. Kyle WB Congenit Heart Dis; 2012; 7(6):575-83. PubMed ID: 23075130 [TBL] [Abstract][Full Text] [Related]
53. [Hypertension of the lesser circulation in atherosclerotic cardiosclerosis]. Iurenev PN; Levina SI; Aleksandrov OV; Gerasimova AA Ter Arkh; 1966 Dec; 39(12):78-84. PubMed ID: 6004402 [No Abstract] [Full Text] [Related]
54. Assessment of operability of congenital cardiac shunts with increased pulmonary vascular resistance. Viswanathan S; Kumar RK Catheter Cardiovasc Interv; 2008 Apr; 71(5):665-70. PubMed ID: 18360864 [TBL] [Abstract][Full Text] [Related]